CQ-MCI: a potential efficient cognitive screeningscale for mild cognitive impairment

Zixuan LIAO, Jiayu LI, Yidan LIU, Shuchun HUANG, Liumi JIANG, Xiaofeng LI

Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (1) : 29-35.

PDF(906 KB)
Home Journals Chinese Journal of Alzheimer's Disease and Related Disorders
Chinese Journal of Alzheimer's Disease and Related Disorders

Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders      Editor in chief: Jun WANG

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(906 KB)
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (1) : 29-35. DOI: 10.3969/j.issn.2096-5516.2025.01.005

CQ-MCI: a potential efficient cognitive screeningscale for mild cognitive impairment

Author information +
History +

Abstract

Objective:

Mild cognitive impairment (MCI) represents a crucial stage in the early diagnosis and intervention of dementia. MCI due to AD is the main type of MCI. Using a single cognitive screening scale for MCI has some shortcomings such as limited sensitivity and specificity. Meanwhile, using a comprehensive neuropsychological battery for MCI screening is time consuming and laborintensive. Therefore, this study aims to explore an efficient cognitive screening scale for Chinese population of MCI due to AD, based on previously used cognitive assessment tools.

Methods:

A total of 27 cognitive screening tests and the Clinical Dementia Rating (CDR) scale were administered to 242 participants: 121 in the control group (CDR=0) and 121 in the MCI group (CDR=0.5). Spearman correlation analysis was used to assess the relationship between Z scores of each test and CDR scores. Tests showing significant correlations were used to construct a new screening scale for MCI. Then conduct a preliminary analysis of the sensitivity and specificity of the new scale, and establish the scoring criteria for the new scale.

Results:

The results of the correlation analysis showed that among the neuropsychological tests in various cognitive domains, Visual Cognitive Assessment Test(VCAT)-Language (r=-0.447, P<0.001), VCAT-Memory (r=-0.717, P<0.001), Trail Making Test(TMT)-B (r=0.426, P<0.001), Mini-Mental State Examination(MMSE)-Orientation (r=-0.271, P=0.025), MMSE-Attention (r=-0.313, P=0.009), and Clock Drawing Test(CDT) (r=-0.407, P<0.001) had the strongest correlations with CDR scores. These six cognitive tests were used to construct a new scale. And pass/fail criteria was derived that determined "possible"(one test failed), "probable" (two tests failed), and "definite" MCI (three tests failed).

Conclusion:

VCAT-Language; VCAT-Memory, TMT-B, MMSE-Orientation, MMSE-Attention, and CDT tests can be integrated to form a new screening scale for MCI suitable for the Chinese population of MCI due to AD. Further clinical validation is needed in the future to assess the sensitivity and feasibility of CQ-MCI.

Key words

Mild cognitive impairment / Neuropsychological test / Screening scale

Cite this article

Download Citations
Zixuan LIAO , Jiayu LI , Yidan LIU , et al . CQ-MCI: a potential efficient cognitive screeningscale for mild cognitive impairment[J]. Chinese Journal of Alzheimer's Disease and Related Disorders. 2025, 8(1): 29-35 https://doi.org/10.3969/j.issn.2096-5516.2025.01.005

References

[1]
He S, Dou L, Li X, et al. Review of bioinformatics in Azheimer's disease research[J]. Comput Biol Med, 2022, 143: 105269.
[2]
Patterson C. World Alzheimer report 2018:the state of the art of dementia research: new frontiers[R]. Alzheimer's Disease International, 2018.
[3]
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease[J]. Alzheimers Dement, 2011, 7(3): 280-292.
[4]
Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease[J]. Alzheimers Dement, 2011, 7(3): 270-279.
[5]
Frölich L, Von Arnim C, Bohlken J, et al. Mild cognitive impairment in geriatric practice: patient orientation, diagnostics, treatment and ethics[J]. Z Gerontol Geriatr, 2023, 56(6): 492-497.
[6]
Cong L, Ren Y, Wang Y, et al. Mild cognitive impairment among rural-dwelling older adults in China: a community-based study[J]. Alzheimers Dement, 2023, 19(1): 56-66.
[7]
Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12): e661-e671.
[8]
Sanford AM. Mild cognitive impairment[J]. Clin Geriatr Med, 2017, 33(3): 325-337.
[9]
Morley JE. An overview of cognitive impairment[J]. Clin Geriatr Med, 2018, 34(4): 505-513.
[10]
Jia X, Wang Z, Huang F, et al. A comparison of the mini-mental state examination (MMSE) with the montreal cognitive assessment (MoCA) for mild cognitive impairment screening in chinese middle-aged and older population: a cross-sectional study[J]. BMC Psychiatry, 2021, 21(1): 485.
[11]
Peng Z, Jiang H, Wang X, et al. The efficacy of cognitive training for elderly chinese individuals with mild cognitive impairment[J]. Biomed Res Int, 2019, 2019: 4347281.
[12]
Cummings J. Alzheimer&apos; s disease diagnostic criteria: practical applications[J]. Alzheimers Res Ther, 2012, 4(5): 35.
[13]
田金洲, 解恒革, 秦斌, 等. 中国简短认知测试在痴呆诊断中的应用指南[J]. 中华医学杂志, 2016, 96(37): 2945-5299.
[14]
赵倩, 冯金玉, 洪兆晨, 等. 轻度认知功能障碍早期筛查量表的研究进展[J]. 循证护理, 2023, 9(3): 435-439.
[15]
Salis F, Costaggiu D, Mandas A, et al. Mini-mental state examination: optimal cut-off levels for mild and severe cognitive impairment[J]. Geriatrics (Basel), 2023, 8(1).
[16]
Wei YC, Chen CK, Lin C, et al. Normative data of mini-mental state examination, montreal cognitive assessment, and Alzheimer's disease assessment scale-cognitive subscale of community-dwelling older adults in taiwan[J]. Dement Geriatr Cogn Disord, 2022, 51(4): 365-376.
[17]
Carson N, Leach L, Murphy KJ, et al. A re-examination of montreal cognitive assessment (MoCA) cutoff scores[J]. Int J Geriatr Psychiatry, 2018, 33(2): 379-388.
[18]
Nasreddine ZS, Phillips NA, Bédirian V, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53(4): 695-699.
[19]
Dassanayake TL, Hewawasam C, Baminiwatta A, et al. Sex-, age- and education-adjusted norms for the WHO/UCLA version of the rey auditory verbal learning test for sinhala-speaking sri lankan adults[J]. Clin Neuropsychol, 2020, 34(sup1): 127-142.
[20]
胡盼盼, 周珊珊, 吴兴启, 等. HKU-AHMU成套量表在不同年龄健康人群中的应用[J]. 中国现代神经疾病杂志, 2021, 21(12): 1046-1056.
[21]
Li Y, Qiao Y, Wang F, et al. Culture effects on the chinese version boston naming test performance and the normative data in the native chinese-speaking elders in mainland china[J]. Front Neurol, 2022, 13: 866261.
[22]
Low A, Lim L, Lim L, et al. Construct validity of the visual cognitive assessment test (VCAT)-a cross-cultural language-neutral cognitive screening tool[J]. Int Psychogeriatr, 2020, 32(1): 141-149.
[23]
Kandiah N, Zhang A, Bautista DC, et al. Early detection of dementia in multilingual populations: visual cognitive assessment test (VCAT)[J]. J Neurol Neurosurg Psychiatry, 2016, 87(2): 156-160.
[24]
Soo SA, Kumar D, Leow YJ, et al. Usefulness of the visual cognitive assessment test in detecting mild cognitive impairment in the community[J]. J Alzheimers Dis, 2023, 93(2): 755-763.
[25]
徐珊瑚, 陈林辉, 李雅国, 等. 画钟试验的不同评分方法及在认知筛查中的应用[J]. 中华老年医学杂志, 2018, 37(4): 390-393.
[26]
Maestri G, Nicotra A, Pomati S, et al. Cultural influence on clock drawing test: A systematic review[J]. J Int Neuropsychol Soc, 2023, 29(7): 704-714.
[27]
Huang HC, Tseng YM, Chen YC, et al. Diagnostic accuracy of the clinical dementia rating scale for detecting mild cognitive impairment and dementia: a bivariate meta-analysis[J]. Int J Geriatr Psychiatry, 2021, 36(2): 239-251.
[28]
Hoche F, Guell X, Vangel MG, et al. The cerebellar cognitive affective/Schmahmann syndrome scale[J]. Brain, 2018, 141(1): 248-270.

Footnotes

利益冲突:除基金项目支持外,本文无个人或企业的经济利益。

志谢:感谢新加坡国立神经科学研究所提供VCAT量表的使用授权。

PDF(906 KB)

Accesses

Citation

Detail

Sections
Recommended

/